Page last updated: 2024-11-08

pentylenetetrazole and Disease, Pulmonary

pentylenetetrazole has been researched along with Disease, Pulmonary in 2 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tansini, G1
Cavallaro, G1
Bini, P1
Romagnoli, E1

Other Studies

2 other studies available for pentylenetetrazole and Disease, Pulmonary

ArticleYear
[Clinical considerations on a new antitussive agent].
    Minerva medica, 1971, Feb-28, Volume: 62, Issue:17

    Topics: Adolescent; Adult; Aged; Antitussive Agents; Bronchitis; Codeine; Cough; Female; Humans; Lung Diseas

1971
[Clinical study of the cough sedative, expectorant and eupneic properties of the preparation, "Cardiazol-Paracodin" Knoll].
    Minerva medica, 1971, Feb-28, Volume: 62, Issue:17

    Topics: Bronchial Diseases; Codeine; Cough; Expectorants; Humans; Lung Diseases; Lung Neoplasms; Pentylenete

1971